Demonstration_NN
of_IN
estrogen_NN
and_CC
progesterone_NN
receptors_NNS
as_RB
well_RB
as_IN
Ki-67_NN
and_CC
p-145_NN
antigens_NNS
in_IN
single_JJ
tumor_NN
cells_NNS
from_IN
blood_NN
and_CC
pleural_JJ
effusions_NNS
using_VBG
a_DT
slide_NN
assay_NN
._.

We_PRP
describe_VBP
a_DT
slide_NN
assay_NN
that_WDT
allows_VBZ
the_DT
demonstration_NN
of_IN
antigens_NNS
localized_VBN
in_IN
the_DT
nucleus_NN
from_IN
isolated_VBN
white_JJ
blood_NN
cells_NNS
as_RB
well_RB
as_IN
from_IN
single_JJ
tumor_NN
cells_NNS
derived_VBN
from_IN
malignant_JJ
effusions_NNS
._.

With_IN
the_DT
antibodies_NNS
Ki-67_NN
and_CC
anti-p-145_NN
an_DT
increased_VBN
rate_NN
of_IN
nuclear_JJ
and_CC
nucleolar_JJ
staining_NN
resulted_VBD
in_IN
cells_NNS
from_IN
highly_RB
malignant_JJ
lymphomas_NNS
._.

An_DT
almost_RB
identical_JJ
reaction_NN
was_VBD
obtained_VBN
when_WRB
tumor_NN
cells_NNS
from_IN
malignant_JJ
effusions_NNS
were_VBD
tested_VBN
._.

Cells_NNS
isolated_VBN
from_IN
the_DT
blood_NN
of_IN
patients_NNS
with_IN
leukemic_JJ
spread_NN
of_IN
lymphomas_NNS
of_IN
low_JJ
malignancy_NN
yielded_VBD
a_DT
weak_JJ
staining_NN
comparable_JJ
to_TO
that_DT
of_IN
normal_JJ
mesothelial_JJ
cells_NNS
from_IN
non-tumorous_JJ
cavity_NN
fluids_NNS
._.

The_DT
detection_NN
of_IN
estrogen_NN
and_CC
progesterone_NN
receptors_NNS
-LRB-_-LRB-
ER_NN
and_CC
PR_NN
-RRB-_-RRB-
localized_JJ
in_IN
the_DT
cell_NN
nucleus_NN
can_MD
be_VB
achieved_VBN
by_IN
the_DT
same_JJ
assay_NN
._.

The_DT
reaction_NN
is_VBZ
enhanced_VBN
by_IN
incubation_NN
of_IN
the_DT
tumor_NN
cells_NNS
for_IN
30_CD
min_NN
at_IN
37_CD
degrees_NNS
C_NN
prior_JJ
to_TO
fixation_NN
._.

Pleural_JJ
effusions_NNS
from_IN
20_CD
patients_NNS
with_IN
breast_NN
cancer_NN
were_VBD
tested_VBN
._.

ER_NN
was_VBD
positive_JJ
in_IN
13_CD
and_CC
PR_NN
was_VBD
positive_JJ
in_IN
12_CD
of_IN
the_DT
20_CD
samples_NNS
._.

In_IN
5_CD
cases_NNS
there_EX
was_VBD
a_DT
divergent_JJ
reaction_NN
with_IN
ER_NN
and_CC
PR_NN
antibody_NN
._.

The_DT
hormone_NN
receptors_NNS
of_IN
the_DT
primary_JJ
tumor_NN
were_VBD
known_VBN
in_IN
15_CD
-LRB-_-LRB-
ER_NN
-RRB-_-RRB-
and_CC
14_CD
-LRB-_-LRB-
PR_NN
-RRB-_-RRB-
patients_NNS
,_,
respectively_RB
._.

In_IN
each_DT
cohort_NN
there_EX
was_VBD
only_RB
one_CD
case_NN
with_IN
a_DT
negative_JJ
reaction_NN
of_IN
the_DT
primary_JJ
tumor_NN
and_CC
a_DT
positive_JJ
reaction_NN
with_IN
the_DT
isolated_VBN
tumor_NN
cells_NNS
from_IN
the_DT
pleural_JJ
effusions_NNS
._.

These_DT
results_NNS
indicate_VBP
that_IN
the_DT
demonstration_NN
of_IN
hormone_NN
receptor_NN
proteins_NNS
in_IN
cells_NNS
from_IN
malignant_JJ
effusions_NNS
is_VBZ
possible_JJ
and_CC
that_IN
there_EX
is_VBZ
a_DT
correlation_NN
with_IN
the_DT
status_NN
of_IN
the_DT
primary_JJ
site_NN
of_IN
cancer_NN
._.

